1. Home
  2. DCBO vs CMRX Comparison

DCBO vs CMRX Comparison

Compare DCBO & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCBO
  • CMRX
  • Stock Information
  • Founded
  • DCBO 2016
  • CMRX 2000
  • Country
  • DCBO Canada
  • CMRX United States
  • Employees
  • DCBO N/A
  • CMRX N/A
  • Industry
  • DCBO
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCBO
  • CMRX Health Care
  • Exchange
  • DCBO Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • DCBO 893.8M
  • CMRX 797.3M
  • IPO Year
  • DCBO 2020
  • CMRX 2013
  • Fundamental
  • Price
  • DCBO $28.94
  • CMRX $8.53
  • Analyst Decision
  • DCBO Strong Buy
  • CMRX Hold
  • Analyst Count
  • DCBO 7
  • CMRX 4
  • Target Price
  • DCBO $53.29
  • CMRX $8.51
  • AVG Volume (30 Days)
  • DCBO 70.8K
  • CMRX 2.1M
  • Earning Date
  • DCBO 05-08-2025
  • CMRX 03-21-2025
  • Dividend Yield
  • DCBO N/A
  • CMRX N/A
  • EPS Growth
  • DCBO 975.00
  • CMRX N/A
  • EPS
  • DCBO 0.86
  • CMRX N/A
  • Revenue
  • DCBO $216,931,000.00
  • CMRX $212,000.00
  • Revenue This Year
  • DCBO $13.92
  • CMRX $2,685.38
  • Revenue Next Year
  • DCBO $14.54
  • CMRX $1,050.23
  • P/E Ratio
  • DCBO $34.12
  • CMRX N/A
  • Revenue Growth
  • DCBO 19.96
  • CMRX N/A
  • 52 Week Low
  • DCBO $27.61
  • CMRX $0.75
  • 52 Week High
  • DCBO $53.86
  • CMRX $8.53
  • Technical
  • Relative Strength Index (RSI)
  • DCBO 36.67
  • CMRX 83.41
  • Support Level
  • DCBO $27.80
  • CMRX $8.41
  • Resistance Level
  • DCBO $30.79
  • CMRX $8.52
  • Average True Range (ATR)
  • DCBO 1.14
  • CMRX 0.02
  • MACD
  • DCBO 0.35
  • CMRX -0.15
  • Stochastic Oscillator
  • DCBO 25.39
  • CMRX 100.00

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: